The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

Igh-V3609N  -  immunoglobulin heavy chain (V3609N non...

Mus musculus

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Igh-V3609N


Psychiatry related information on Igh-V3609N


High impact information on Igh-V3609N


Biological context of Igh-V3609N


Anatomical context of Igh-V3609N


Associations of Igh-V3609N with chemical compounds


Physical interactions of Igh-V3609N


Enzymatic interactions of Igh-V3609N


Regulatory relationships of Igh-V3609N


Other interactions of Igh-V3609N


Analytical, diagnostic and therapeutic context of Igh-V3609N


  1. Role of the octamer motif in hybrid cell extinction of immunoglobulin gene expression: extinction is dominant in a two enhancer system. Yu, H., Porton, B., Shen, L.Y., Eckhardt, L.A. Cell (1989) [Pubmed]
  2. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Battey, J., Moulding, C., Taub, R., Murphy, W., Stewart, T., Potter, H., Lenoir, G., Leder, P. Cell (1983) [Pubmed]
  3. T-cell-receptor beta- and I-A beta-chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB x SWR crosses. Ghatak, S., Sainis, K., Owen, F.L., Datta, S.K. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  4. Purified mu EBP-E binds to immunoglobulin enhancers and promoters. Peterson, C.L., Eaton, S., Calame, K. Mol. Cell. Biol. (1988) [Pubmed]
  5. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma. Voso, M.T., Hohaus, S., Moos, M., Haas, R. Blood (1997) [Pubmed]
  6. Rapid induction of IgM-secreting murine plasmacytomas by pristane and an immunoglobulin heavy-chain promoter/enhancer-driven c-myc/v-Ha-ras retrovirus. Clynes, R., Wax, J., Stanton, L.W., Smith-Gill, S., Potter, M., Marcu, K.B. Proc. Natl. Acad. Sci. U.S.A. (1988) [Pubmed]
  7. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Lam, K.P., Kühn, R., Rajewsky, K. Cell (1997) [Pubmed]
  8. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Smith, A.J., De Sousa, M.A., Kwabi-Addo, B., Heppell-Parton, A., Impey, H., Rabbitts, P. Nat. Genet. (1995) [Pubmed]
  9. B cell development regulated by gene rearrangement: arrest of maturation by membrane-bound D mu protein and selection of DH element reading frames. Gu, H., Kitamura, D., Rajewsky, K. Cell (1991) [Pubmed]
  10. Isotype switching of an immunoglobulin heavy chain transgene occurs by DNA recombination between different chromosomes. Gerstein, R.M., Frankel, W.N., Hsieh, C.L., Durdik, J.M., Rath, S., Coffin, J.M., Nisonoff, A., Selsing, E. Cell (1990) [Pubmed]
  11. Trans-acting nuclear protein responsible for induction of rearranged human immunoglobulin heavy chain gene. Maeda, H., Kitamura, D., Kudo, A., Araki, K., Watanabe, T. Cell (1986) [Pubmed]
  12. The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice. Xue, K., Rada, C., Neuberger, M.S. J. Exp. Med. (2006) [Pubmed]
  13. The mouse immunoglobulin heavy-chain enhancer: effect on transcription in vitro and binding of proteins present in HeLa and lymphoid B cell extracts. Augereau, P., Chambon, P. EMBO J. (1986) [Pubmed]
  14. B cells expressing a natural polyreactive autoantibody have a distinct phenotype and are overrepresented in immunoglobulin heavy chain transgenic mice. Tian, Q., Beardall, M., Xu, Y., Li, J., Parker, D.C., Casanova, N., Bakke, A.C., Chen, C. J. Immunol. (2006) [Pubmed]
  15. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Madisen, L., Groudine, M. Genes Dev. (1994) [Pubmed]
  16. C mu-containing transcripts initiate heterogeneously within the IgH enhancer region and contain a novel 5'-nontranslatable exon. Lennon, G.G., Perry, R.P. Nature (1985) [Pubmed]
  17. The half-life of immunoglobulin mRNA increases during B-cell differentiation: a possible role for targeting to membrane-bound polysomes. Mason, J.O., Williams, G.T., Neuberger, M.S. Genes Dev. (1988) [Pubmed]
  18. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Nutt, S.L., Urbánek, P., Rolink, A., Busslinger, M. Genes Dev. (1997) [Pubmed]
  19. The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cells. Wasylyk, C., Wasylyk, B. EMBO J. (1986) [Pubmed]
  20. Mutational analysis of the immunoglobulin heavy chain promoter region. Ballard, D.W., Bothwell, A. Proc. Natl. Acad. Sci. U.S.A. (1986) [Pubmed]
  21. Transient IL-7/IL-7R signaling provides a mechanism for feedback inhibition of immunoglobulin heavy chain gene rearrangements. Chowdhury, D., Sen, R. Immunity (2003) [Pubmed]
  22. Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells. Chen, U., Scheuermann, R.H., Wirth, T., Gerster, T., Roeder, R.G., Harshman, K., Berger, C. Nucleic Acids Res. (1991) [Pubmed]
  23. Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. Ippolito, G.C., Schelonka, R.L., Zemlin, M., Ivanov, I.I., Kobayashi, R., Zemlin, C., Gartland, G.L., Nitschke, L., Pelkonen, J., Fujihashi, K., Rajewsky, K., Schroeder, H.W. J. Exp. Med. (2006) [Pubmed]
  24. Myristoylation and the post-translational acquisition of hydrophobicity by the membrane immunoglobulin heavy-chain polypeptide in B lymphocytes. Pillai, S., Baltimore, D. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  25. Proteins binding to site C2 (muE3) in the immunoglobulin heavy-chain enhancer exist in multiple oligomeric forms. Peterson, C.L., Calame, K. Mol. Cell. Biol. (1989) [Pubmed]
  26. Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. Roman, C., Platero, J.S., Shuman, J., Calame, K. Genes Dev. (1990) [Pubmed]
  27. A dominant negative form of transcription activator mTFE3 created by differential splicing. Roman, C., Cohn, L., Calame, K. Science (1991) [Pubmed]
  28. Pax5 (BSAP) regulates the murine immunoglobulin 3' alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription. Neurath, M.F., Max, E.E., Strober, W. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  29. Repression of an interleukin-4-responsive promoter requires cooperative BCL-6 function. Harris, M.B., Mostecki, J., Rothman, P.B. J. Biol. Chem. (2005) [Pubmed]
  30. Duplication/deficiency mapping of situs inversus viscerum (iv), a gene that determines left-right asymmetry in the mouse. McGrath, J., Horwich, A.L., Brueckner, M. Genomics (1992) [Pubmed]
  31. RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. Chen, J., Lansford, R., Stewart, V., Young, F., Alt, F.W. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  32. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Fuxa, M., Skok, J., Souabni, A., Salvagiotto, G., Roldan, E., Busslinger, M. Genes Dev. (2004) [Pubmed]
  33. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. Dildrop, R., Ma, A., Zimmerman, K., Hsu, E., Tesfaye, A., DePinho, R., Alt, F.W. EMBO J. (1989) [Pubmed]
  34. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. Wang, J., Boxer, L.M. J. Biol. Chem. (2005) [Pubmed]
  35. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Bertolino, E., Reddy, K., Medina, K.L., Parganas, E., Ihle, J., Singh, H. Nat. Immunol. (2005) [Pubmed]
  36. Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator. Wang, Z., Goldstein, A., Zong, R.T., Lin, D., Neufeld, E.J., Scheuermann, R.H., Tucker, P.W. Mol. Cell. Biol. (1999) [Pubmed]
  37. Regulation of anti-Sm autoantibodies by the immunoglobulin heavy chain locus. Halpern, M.D., Craven, S.Y., Cohen, P.L., Eisenberg, R.A. J. Immunol. (1993) [Pubmed]
  38. Mapping of the mouse 86-kDa heat-shock protein expressed gene (Hsp86-1) on chromosome 12 and related genes on chromosomes 3, 4, 9, and 11. Moore, S.K., Appella, E., Villar, C.J., Kozak, C.A. Genomics (1991) [Pubmed]
  39. Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cgamma1 heavy of Ckappa light chain gene segments. Pluschke, G., Joss, A., Marfurt, J., Daubenberger, C., Kashala, O., Zwickl, M., Stief, A., Sansig, G., Schläpfer, B., Linkert, S., van der Putten, H., Hardman, N., Schröder, M. J. Immunol. Methods (1998) [Pubmed]
  40. Evaluation of antisense inhibition in a B cell model. McCall, M.N., Kuchel, M.G., Basten, A. Biochem. Mol. Biol. Int. (1997) [Pubmed]
  41. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Banerji, J., Olson, L., Schaffner, W. Cell (1983) [Pubmed]
  42. Mouse lymphoid cell line selected to have high immunoglobulin promoter activity. Tantin, D., Sharp, P.A. Mol. Cell. Biol. (2002) [Pubmed]
  43. Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice. Steenbergen, E.J., Verhagen, O.J., Nibbering, C.P., van den Berg, H., van Leeuwen, E.F., Behrendt, H., von dem Borne, A.E., van der Schoot, C.E. Leukemia (1996) [Pubmed]
  44. Measurement of recombinase activity in a set of related Abelson murine leukemic virus pre-B cell lines: DJ/DJ lines have more recombinase activity than do VDJ/VDJ lines. Eisen, A.F., Atkinson, M.J., Celler, J.W., Paige, C.J., Wu, G.E. Int. Immunol. (1991) [Pubmed]
  45. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice. Ward, J.M., Tadesse-Heath, L., Perkins, S.N., Chattopadhyay, S.K., Hursting, S.D., Morse, H.C. Lab. Invest. (1999) [Pubmed]
  46. Abnormalities in the glycosylation of immunoglobulin heavy chain and an h-2 transplantation antigen in a mouse myeloma mutant. Weitzman, S., Nathenson, S.G., Scharff, M.D. Cell (1977) [Pubmed]
WikiGenes - Universities